NCT03780959 2019-08-02
Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)
Amgen
Phase 2/3 Completed
Clinical Trials
3 trialsNCT00001862 2008-03-04
TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00012506 2005-06-24
The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis
National Eye Institute (NEI)
Phase 3 Unknown